Urinary metabolites of 1,3-butadiene, benzene and toluene and colorectal cancer incidence: a clinical case–control study | Synapse
March 3, 2026
Urinary metabolites of 1,3-butadiene, benzene and toluene and colorectal cancer incidence: a clinical case–control study
Key Points
Colorectal cancer incidence is associated with elevated urinary metabolites from 1,3-butadiene, benzene, and toluene.
Participants in the study displayed significant differences in metabolite levels, especially those diagnosed with cancer.
Observational analysis of urinary metabolites focused on individuals with varying colorectal cancer status, aiding in understanding environmental influences.
Findings imply that monitoring urinary metabolites may help assess cancer risk linked to environmental toxins.